Doppler study of myometrium in invasive gestational trophoblastic disease
作者： S. Oguz , A. Sargin , H. Aytan , S. Kelekci , H. Dumanli
DOI: 10.1111/J.1048-891X.2004.14537.X
关键词:
摘要: Objective In this prospective study, we aimed to assess the prognostic and diagnostic role of color Doppler flow myometrium in patients with invasive gestational trophoblastic disease (GTD). Methods Thirty-seven patients, who were enrolled study mole, assessed help transvaginal ultrasound before after chemotherapy. The place size myometrial invasions assessed. Results Thirty 37 treated single-agent chemotherapy – methotrexate (mtx). group, resistance index (RI) ratios ranged between 0.26 0.45 invasion varied 10 50 mm. On other hand, six mtx actinomycin D combination one patient was total abdominal hysterectomy. RI 0.16 0.25 60 90 Remission achieved all patients. Conclusion Transvaginal can easily detect GTD. When depth width increase when there is a low diastolic/systolic ratio, number courses need for increase.
sci-hub.se 参考文章(30)
Fiorica Jv, Hoffman Ms, Robert Ws, Gleeson Nc, Finan Ma, Wilson J, Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid. European Journal of Gynaecological Oncology. ,vol. 14, pp. 461- ,(1993)
Charles B. Hammond, Roy Hertz, Griff T. Ross, Mortimer B. Lipsett, William D. Odell, Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms American Journal of Obstetrics and Gynecology. ,vol. 98, pp. 71- 78 ,(1967) , 10.1016/0002-9378(67)90134-2
Ellen Blair Smith, John C. Weed, Lee Tyrey, Charles B. Hammond, Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate--folinic acid. American Journal of Obstetrics and Gynecology. ,vol. 144, pp. 88- 92 ,(1982) , 10.1016/0002-9378(82)90400-8
STEPHEN L. CURRY, CHARLES B. HAMMOND, LEE TYREY, WILLIAM T. CREASMAN, ROY T. PARKER, Hydatidiform mole: diagnosis, management, and long-term followup of 347 patients Obstetrics & Gynecology. ,vol. 45, pp. 1- 8 ,(1975) , 10.1097/00006254-197507000-00025
A Kurjak, I Zalud, M Predanic, S Kupesic, Transvaginal color and pulsed Doppler study of uterine blood flow in the first and early second trimesters of pregnancy: normal versus abnormal. Journal of Ultrasound in Medicine. ,vol. 13, pp. 43- 47 ,(1994) , 10.7863/JUM.1994.13.1.43
Naoki Tsukamoto, Tsuyoshi Iwasaka, Yoshiko Kashimura, Hideyuki Uchino, Masamichi Kashimura, Toshitaka Matsuyama, Gestational trophoblastic disease in women aged 50 or more. Gynecologic Oncology. ,vol. 20, pp. 53- 61 ,(1985) , 10.1016/0090-8258(85)90124-6
John R. Lurain, Elizabeth P. Elfstrand, Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors☆☆☆ American Journal of Obstetrics and Gynecology. ,vol. 172, pp. 574- 579 ,(1995) , 10.1016/0002-9378(95)90575-8
Hung-chao Sung, Pao-chen Wu, Hsiu-yu Yang, Reevaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasms. American Journal of Obstetrics and Gynecology. ,vol. 150, pp. 69- 75 ,(1984) , 10.1016/S0002-9378(84)80112-X
Howard D. Homesley, John A. Blessing, John Schlaerth, Mark Rettenmaier, Francis J. Major, Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: a Gynecologic Oncology Group study. Gynecologic Oncology. ,vol. 39, pp. 305- 308 ,(1990) , 10.1016/0090-8258(90)90257-L
HD Homesley, JA Blessing, M Rettenmaier, RL Capizzi, FJ Major, LB Twiggs, Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstetrics & Gynecology. ,vol. 72, pp. 413- 418 ,(1989) , 10.1016/0020-7292(89)90779-0